SCYNEXIS, Inc. (SCYX) - Latest Market Data

Price & Market Data

Price: $0.624

Daily Change: -$0.086 / 13.78%

Daily Range: $0.605 - $0.736

Market Cap: $58,096,396

Daily Volume: 422,824

Performance Metrics

1 Week: -5.79%

1 Month: -31.57%

3 Months: -10.44%

6 Months: 0.75%

1 Year: -8.18%

YTD: 14.72%

About SCYNEXIS, Inc. (SCYX)

A detailed overview of SCYNEXIS, Inc. (SCYX) reveals a price of 0.624 and a daily shift of -$0.086 / 13.78%. The market cap is currently 58,096,396. Comprehensive performance figures for 1-week (-5.79%) and 3-month (-10.44%) periods are available.

Company Details

Employees: 18

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

Selected stocks

Baozun Inc. (BZUN)

Cabaletta Bio, Inc. (CABA)

Under Armour, Inc. (UAA)

SaverOne 2014 Ltd. (SVRE)